Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN

Advances in Experimental Medicine and Biology

Volumn 437, Issue , 1998, Pages 223-229

  Noe, Sasha N ^a   Nyland, Susan B ^a   Ugen, Kenneth ^a   Friedman, Herman ^a   Klein, Thomas W ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABIS; DRONABINOL; MESSENGER RNA;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABUSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIUM; VIRUS INFECTIVITY; VIRUS REPLICATION;

CANNABIS; CANNABIS SATIVA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031873419     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5347-2_25     Document Type: Article

References (21)

1. Blanchard, D. K., C. Newton, T.W. Klein, W.E. II Stewart and H. In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells. Int. J. Immunopharm. 8:819-824, 1986.
2. Bour, S., Gelezuinas, R., and Wainberg, M.A. The role of CD4 and its downmodulation in establishment and maintenance of HIV-1 infection. Immunological Reviews. 140:147-71, 1994.
3. 9-Tetrahydrocannabinol is mediated by nuclear factor κB and CB1 cannabinoid receptor. DNA and Cell Biology. 16(3): 301-309, 1997.
4. Devane W.A., L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin. D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
5. Ehlers S. Mielke ME. Blankenstein T. Hahn H. Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity. J. Immunology. 149(9):3016-22, 1992.
6. Gerard, C.M., Mollereau, C., Vassert, G., and Parmentier, M. Molecular cloning of a human cannabinoid receptor. Biochem. J. 279:129-134, 1991.
7. Inoue, M., Djordjijevic, D., Fukuma, T., Reddy, E.P., Yokoyama, M.M., and Sagawa, K. Down-regulation of CD4 molecules by the expression of Nef: a quantitative analysis of CD4 antigens on the cell surface. International Immunology. 5(9): 1067-73.
8. Kinter, L.A., Poli, G., Fox, L., Hardy, E., and Fauci, A.S. HIV replication in IL-2 stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogeneous cytokines. J. Immunol. 154:2448-2459, 1995.
9. Klein, T.W., Newton, C., Widen, R., Friedman, H. Delta-9-THC injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J. Pharm. Exp. Ther. 267:635-640, 1993.
10. Klein, T.W., Y. Kawakami, C. Newton, and H. Friedman. Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J. Toxicol. Environ. Health. 32:465-477, 1991.
11. Luo, Y.D., M.K. Patel, M.D. Weiderhold, and D.W. Ou. Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. Int. J. Immunopharm. 14:49-56, 1992.
12. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., and Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:561-564, 1990.
13. Mechoulam, R., S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, A.R. Schatz, A. Gopher, S. Almog, B.R. Martin, D.R. Compton, R.G. Pertwee, G. Griffin, M. Bayewitch, J. Barg, and Z, Vogel. Identification of an endogeneous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharm. 50:83-90, 1995.
14. Munro, S., Thomas, K.L., and Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65, 1993.
15. Nahas, G.G., N. Suciu-Foca, J.P. Armand, and A. Morishima. Inhibition of cellular mediated immunity in marihuana smokers. Science 183:419-420, 1974.
16. Pross, S. H., T.W. Klein, C.A. Newton, and H. Friedman. Differential effects of marijuana components on proliferation of spleen, lymph node and thymus cells in vitro. Int. J. Immunopharm. 9:363-370, 1987.
17. Rinaldi-Carmona, M., F. Barth, M. Heaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Neliat, D. Caput, P. Ferrara, P. Soubrie, J.C. Brelier, and G. Le Fur. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters. 350:240-244, 1994.
18. Shire, D., Carillon, C., Kaghad, M., Calandra, B., Ranald-Carmona, M., Le Fur, G., Caput, D., and Ferrara, P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biological Chem. 270:3726-3731, 1995.
19. Smith, P.B., D. R. Compton, S.P. Welch, R.K. Razdan, R. Mechoulam, and B.R. Martin. The pharmacological activity of anandamide, a putative endogeneous cannabinoid, in mice. J. Pharm. Exp. Ther. 270:219-227, 1994
20. 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits. J. Pharm. Exp. Ther. 274 (2): 1001-1001, 1995.
21. Zhu, W., Newton, C., Daaka, Y., Friedman, H., and Klein, T. 9-Tetrahydrocannabinol enhances the secretion of Interleukin 1 from endotoxin-stimulated macrophages. J. Pharm. Exp. Ther. 270:1334-1339, 1994.